annual shareholders equity:
$29.35B+$3.38B(+13.02%)Summary
- As of today (May 29, 2025), REGN annual stockholders equity is $29.35 billion, with the most recent change of +$3.38 billion (+13.02%) on December 31, 2024.
- During the last 3 years, REGN annual shareholders equity has risen by +$10.58 billion (+56.40%).
- REGN annual shareholders equity is now at all-time high.
Performance
REGN Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$29.39B+$34.00M(+0.12%)Summary
- As of today (May 29, 2025), REGN quarterly stockholders equity is $29.39 billion, with the most recent change of +$34.00 million (+0.12%) on March 31, 2025.
- Over the past year, REGN quarterly shareholders equity has increased by +$2.40 billion (+8.88%).
- REGN quarterly shareholders equity is now at all-time high.
Performance
REGN quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
REGN Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.0% | +8.9% |
| 3 y3 years | +56.4% | +47.6% |
| 5 y5 years | +164.7% | +142.2% |
REGN Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +56.4% | at high | +47.6% |
| 5 y | 5-year | at high | +166.2% | at high | +224.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
REGN Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $29.39B(+0.1%) |
| Dec 2024 | $29.35B(+13.0%) | $29.35B(+0.1%) |
| Sep 2024 | - | $29.33B(+4.0%) |
| Jun 2024 | - | $28.21B(+4.5%) |
| Mar 2024 | - | $26.99B(+3.9%) |
| Dec 2023 | $25.97B(+14.6%) | $25.97B(+4.3%) |
| Sep 2023 | - | $24.90B(+3.7%) |
| Jun 2023 | - | $24.02B(+2.2%) |
| Mar 2023 | - | $23.50B(+3.7%) |
| Dec 2022 | $22.66B(+20.8%) | $22.66B(+5.7%) |
| Sep 2022 | - | $21.44B(+3.6%) |
| Jun 2022 | - | $20.69B(+3.9%) |
| Mar 2022 | - | $19.91B(+6.1%) |
| Dec 2021 | $18.77B(+70.2%) | $18.77B(+8.8%) |
| Sep 2021 | - | $17.26B(+14.1%) |
| Jun 2021 | - | $15.13B(+26.3%) |
| Mar 2021 | - | $11.98B(+8.6%) |
| Dec 2020 | $11.03B(-0.6%) | $11.03B(+8.9%) |
| Sep 2020 | - | $10.13B(+11.8%) |
| Jun 2020 | - | $9.06B(-25.3%) |
| Mar 2020 | - | $12.13B(+9.4%) |
| Dec 2019 | $11.09B(+26.6%) | $11.09B(+5.6%) |
| Sep 2019 | - | $10.50B(+7.7%) |
| Jun 2019 | - | $9.76B(+3.3%) |
| Mar 2019 | - | $9.44B(+7.8%) |
| Dec 2018 | $8.76B(+42.5%) | $8.76B(+11.3%) |
| Sep 2018 | - | $7.87B(+9.5%) |
| Jun 2018 | - | $7.19B(+9.4%) |
| Mar 2018 | - | $6.57B(+6.9%) |
| Dec 2017 | $6.14B(+38.1%) | $6.14B(+1.5%) |
| Sep 2017 | - | $6.05B(+9.6%) |
| Jun 2017 | - | $5.52B(+13.5%) |
| Mar 2017 | - | $4.87B(+9.4%) |
| Dec 2016 | $4.45B(+21.7%) | $4.45B(-0.9%) |
| Sep 2016 | - | $4.49B(+10.2%) |
| Jun 2016 | - | $4.08B(+8.3%) |
| Mar 2016 | - | $3.77B(+3.0%) |
| Dec 2015 | $3.65B(+43.3%) | $3.65B(+10.9%) |
| Sep 2015 | - | $3.30B(-1.2%) |
| Jun 2015 | - | $3.34B(+12.4%) |
| Mar 2015 | - | $2.97B(+16.5%) |
| Dec 2014 | $2.55B(+30.6%) | $2.55B(-0.1%) |
| Sep 2014 | - | $2.55B(+7.7%) |
| Jun 2014 | - | $2.37B(+7.1%) |
| Mar 2014 | - | $2.21B(+13.3%) |
| Dec 2013 | $1.95B(+56.7%) | $1.95B(+15.5%) |
| Sep 2013 | - | $1.69B(+13.2%) |
| Jun 2013 | - | $1.49B(+6.2%) |
| Mar 2013 | - | $1.41B(+12.9%) |
| Dec 2012 | $1.25B(+156.4%) | $1.25B(+54.5%) |
| Sep 2012 | - | $806.02M(+35.5%) |
| Jun 2012 | - | $594.66M(+18.0%) |
| Mar 2012 | - | $504.02M(+3.8%) |
| Dec 2011 | $485.73M(-8.0%) | $485.73M(+13.4%) |
| Sep 2011 | - | $428.25M(-10.4%) |
| Jun 2011 | - | $478.03M(-7.7%) |
| Mar 2011 | - | $518.09M(-1.8%) |
| Dec 2010 | $527.82M(+33.0%) | $527.82M(+51.6%) |
| Sep 2010 | - | $348.06M(-6.2%) |
| Jun 2010 | - | $371.22M(-3.9%) |
| Mar 2010 | - | $386.27M(-2.6%) |
| Dec 2009 | $396.76M(-5.9%) | $396.76M(-6.1%) |
| Sep 2009 | - | $422.44M(+2.9%) |
| Jun 2009 | - | $410.51M(+0.0%) |
| Mar 2009 | - | $410.32M(-2.7%) |
| Dec 2008 | $421.51M | $421.51M(-3.5%) |
| Sep 2008 | - | $436.93M(-3.1%) |
| Jun 2008 | - | $451.00M(-2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $460.60M(+0.1%) |
| Dec 2007 | $460.27M(+112.5%) | $460.27M(+204.0%) |
| Sep 2007 | - | $151.40M(-15.6%) |
| Jun 2007 | - | $179.34M(-8.8%) |
| Mar 2007 | - | $196.69M(-9.2%) |
| Dec 2006 | $216.62M(+90.0%) | $216.62M(+246.7%) |
| Sep 2006 | - | $62.47M(-25.4%) |
| Jun 2006 | - | $83.77M(-18.1%) |
| Mar 2006 | - | $102.32M(-10.2%) |
| Dec 2005 | $114.00M(-37.5%) | $114.00M(-16.4%) |
| Sep 2005 | - | $136.38M(-17.4%) |
| Jun 2005 | - | $165.06M(-11.2%) |
| Mar 2005 | - | $185.78M(+1.8%) |
| Dec 2004 | $182.54M(+32.6%) | $182.54M(+2.1%) |
| Sep 2004 | - | $178.87M(-5.9%) |
| Jun 2004 | - | $190.13M(-6.8%) |
| Mar 2004 | - | $204.11M(+48.3%) |
| Dec 2003 | $137.64M(-5.7%) | $137.64M(-11.9%) |
| Sep 2003 | - | $156.20M(+13.3%) |
| Jun 2003 | - | $137.84M(-16.8%) |
| Mar 2003 | - | $165.62M(+13.4%) |
| Dec 2002 | $145.98M(-45.2%) | $145.98M(-19.3%) |
| Sep 2002 | - | $180.79M(-15.2%) |
| Jun 2002 | - | $213.16M(-12.1%) |
| Mar 2002 | - | $242.48M(-9.0%) |
| Dec 2001 | $266.36M(+46.2%) | $266.36M(-9.7%) |
| Sep 2001 | - | $294.87M(-5.9%) |
| Jun 2001 | - | $313.29M(-3.4%) |
| Mar 2001 | - | $324.41M(+78.1%) |
| Dec 2000 | $182.13M(+66.3%) | $182.13M(-4.6%) |
| Sep 2000 | - | $190.97M(+8.5%) |
| Jun 2000 | - | $175.97M(+66.6%) |
| Mar 2000 | - | $105.59M(-3.6%) |
| Dec 1999 | $109.50M(-16.5%) | $109.50M(-0.9%) |
| Sep 1999 | - | $110.50M(-4.2%) |
| Jun 1999 | - | $115.40M(-6.5%) |
| Mar 1999 | - | $123.40M(-5.9%) |
| Dec 1998 | $131.20M(-5.5%) | $131.20M(-4.2%) |
| Sep 1998 | - | $136.90M(-0.7%) |
| Jun 1998 | - | $137.80M(+1.8%) |
| Mar 1998 | - | $135.40M(-2.5%) |
| Dec 1997 | $138.90M(+29.9%) | $138.90M(+0.5%) |
| Sep 1997 | - | $138.20M(-1.2%) |
| Jun 1997 | - | $139.90M(+38.5%) |
| Mar 1997 | - | $101.00M(-5.5%) |
| Dec 1996 | $106.90M(+57.4%) | $106.90M(+2.6%) |
| Sep 1996 | - | $104.20M(-7.6%) |
| Jun 1996 | - | $112.80M(+81.6%) |
| Mar 1996 | - | $62.10M(-8.5%) |
| Dec 1995 | $67.90M(+1.2%) | $67.90M(+28.1%) |
| Sep 1995 | - | $53.00M(-10.8%) |
| Jun 1995 | - | $59.40M(-6.9%) |
| Mar 1995 | - | $63.80M(-4.9%) |
| Dec 1994 | $67.10M(-31.8%) | $67.10M(-7.8%) |
| Sep 1994 | - | $72.80M(-5.0%) |
| Jun 1994 | - | $76.60M(-11.6%) |
| Mar 1994 | - | $86.70M(-11.9%) |
| Dec 1993 | $98.40M(+12.8%) | $98.40M(-10.6%) |
| Sep 1993 | - | $110.10M(+61.0%) |
| Jun 1993 | - | $68.40M(-12.1%) |
| Mar 1993 | - | $77.80M(-10.8%) |
| Dec 1992 | $87.20M(-17.9%) | $87.20M(-6.7%) |
| Sep 1992 | - | $93.50M(-5.8%) |
| Jun 1992 | - | $99.30M(-3.6%) |
| Mar 1992 | - | $103.00M(-3.0%) |
| Dec 1991 | $106.20M(+770.5%) | $106.20M(-2.0%) |
| Sep 1991 | - | $108.40M(-0.8%) |
| Jun 1991 | - | $109.30M(+795.9%) |
| Dec 1990 | $12.20M | $12.20M |
FAQ
- What is Regeneron Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual shareholders equity year-on-year change?
- What is Regeneron Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Regeneron Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of REGN is $29.35B
What is the all time high annual shareholders equity for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual stockholders equity is $29.35B
What is Regeneron Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, REGN annual stockholders equity has changed by +$3.38B (+13.02%)
What is Regeneron Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of REGN is $29.39B
What is the all time high quarterly shareholders equity for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly stockholders equity is $29.39B
What is Regeneron Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, REGN quarterly stockholders equity has changed by +$2.40B (+8.88%)